This site uses cookies. By continuing to use this site you agree to our use of cookies. To find out more, see our Privacy and Cookies policy.
Skip to the content

IOP A community website from IOP Publishing

Key supplier

Products from this company

  1. First US patients receive Esteya electronic brachytherapy for skin cancer Mar 6, 2014

    Patient-friendly treatment helps minimize radiation exposure to healthy tissues.

  2. Elekta Neuroscience Products and Solutions Mar 3, 2014

    Creating new treatment possibilities for the most challenging cancers and brain disorders.

  3. Elekta Oncology treatment solutions and techniques Mar 3, 2014

    Creating flexible and efficient innovations for the care of people with cancer.

  4. Elekta Software Mar 3, 2014

    Providing human-centric software solutions to improve workflow and patient care.

  5. Elekta Brachytherapy Mar 3, 2014

    Precise solutions for brachytherapy treatment.

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders.

The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives. Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.

Elekta image

Request Info

All fields are mandatory unless marked as optional.

Your details

By submitting this form I consent to Elekta, Inc. contacting me, using the contact details displayed above.